If you’ve ever wondered what role the federal government plays in your healthcare (especially after a breast cancer diagnosis), you’re not alone. Many people may be surprised to learn that while the federal government helps fund healthcare, it doesn’t directly provide hospital or doctor services. Still, it plays several important roles that can affect your treatment and care. Here’s a breakdown of what the federal government does do, how it can matter to you, and some ways you can get involved in advocacy.

Are you ready to lace up your running shoes for a great cause? On October 18 and 19, 2025, thousands of participants will hit the streets for the TCS Toronto Waterfront Marathon, and this year, you can make every step count by fundraising for the Canadian Breast Cancer Network (CBCN)!

Every October, the world turns pink to highlight Breast Cancer Awareness Month. Social media floods with pink ribbons, brands roll out special edition products, and awareness campaigns gain momentum. But for those impacted by breast cancer, whether they’ve been diagnosed themselves, have a loved one who has, or work in research or care, the experience lasts well beyond one month a year.

With the 2025 federal election underway, many of us are thinking about the issues that matter most. These uncertain economic times are at the top of our minds, and ensuring access to healthcare is a crucial part of that. Here are some of the most important healthcare issues to consider in relation to the election.

If you are faced with a breast cancer diagnosis, timely access to care is crucial, but each person will experience wait times in a different way. For some, a bit of waiting is a normal part of the process and is not necessarily cause for concern. For others, delays can cause anxiety and impact the course of their treatment. When navigating the uncertainties of a breast cancer diagnosis, understanding wait times and their potential impacts on health outcomes is essential. That’s why it is important to know what to expect and take the necessary steps in case you experience long delays.

March 3^rd is recognized as Triple Negative Breast Cancer (TNBC) Day. While its aggressive nature and fewer treatment options can be distressing for those living with TNBC, access to information and support resources also continues to grow and improve. Seeking help, staying informed, and keeping in tune with your own experiences and emotions can help you feel more in control of your journey. Here, we present a list of educational and support resources for those diagnosed with TNBC.

As we look back on 2024, we take a moment to reflect. This year has been one of growth, impact, and unwavering commitment to supporting breast cancer patients and their caregivers. Through donations, advocacy, networking, and your stories we've made significant progress in raising awareness, bringing you critical research, and providing vital resources and education for patients and their families.

As we look ahead to 2025, we reflect on the incredible strides made in breast cancer awareness, research, and support. The past year brought new insights, inspiring stories, and innovative developments in breast cancer research. To kick off the new year, we've curated a list of blog posts that have generated the greatest interest in our community over the past year.

. This year, Giving Tuesday will take place tomorrow, on December 3rd. Established in the U.S. in 2012, Giving Tuesday is now a worldwide movement focused on generosity, giving, and volunteering. Although it’s officially observed on the first Tuesday after Black Friday, the spirit and impact of Giving Tuesday often extends well beyond just 24 hours.

The world of cancer treatment is rapidly advancing. Scientists are discovering new ways to target cancers, making drugs more effective and more precise. But with these new advancements, comes a long process of approvals involving many steps to allow Canadians to access them. Not only do new drugs need to be approved for safety and efficacy by regulatory bodies like Health Canada and the Canadian Drug Agency, but then they also need to go through price negotiations between the drug manufacturers and the provinces . These negotiations set the cost that every province will pay to the drug company once the drug is added to public drug plans.